http://www.bizjournals.com/sanantonio/blog/2013/07/azaya-therapeutics-expands-operations.html
Jul 8, 2013, 11:16am CDT
Azaya Therapeutics expands operations with roll out of Parexo Labs
Here a few of them: cheap viagra overnight Lean beef: Red meats such as ground beef are an excellent source of protein. X-ray aimhousepatong.com commander cialis will help the cardiologist to position the catheter. This drug starts effecting after 45-50 minutes and remains effective cialis 5mg sale for about 4 hours. Men aged 35 to 45, having a BMI of >25 and especially those with a BMI of cialis pill from india >30 exhibit a poorer ovarian response to fertility drugs (impaired follicle and embryo development with fewer blastocysts becoming available for transfer). Azaya Therapeutics has created a new division that can perform contract development and manufacturing on behalf of outside firms.
Azaya Therapeutics Inc. has launched a new division called Parexo Labs. The new entity will operate as a contract development and manufacturing organization, and will provide chemical testing and liposomal manufacturing services to outside organizations.
San Antonio-based Azaya is a privately held oncology company focused on developing more effective cancer treatments through its nanotechnology platform. Parexo Labs will leverage Azaya’s twin capabilities in cytotoxic and nanoparticle analysis and liposome manufacturing, including its proprietary analytical methodology, to detail release rates and characterization attributes of nanoparticles.
“Azaya Therapeutics has over 10 years of experience in the cytotoxic and nanotechnology arenas, which we are now leveraging with the roll out of Parexo Labs,” says Azaya President and CEO Mike Dwyer. “Through Parexo, we can apply these analytical capabilities and development methodologies to organizations in need of them for their own development programs.”